Prime
Treatments
Testing and Advancements Index
The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.
FACT SHEET
Prime Treatments, Testing and Advancements Primer
PDF
Infectious Diseases: Prime Treatments, Testing and Advancements Overview
PDF
Prime Treatments, Testing and Advancements Index Methodology Guide
PDF
Prime Treatments, Testing and Advancements Factsheet
PDF
Prime Treatments, Testing and Advancements Index
VIDEO
INDEX KEY FACTS
Base Date: December 12, 2019
Total number of holdings:
62
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization
INDEX SYMBOLS
| Version | Bloomberg | Reuters | ISIN |
|---|---|---|---|
| Prime Treatments, Testing and Advancements Index GTR | PGERM | .PGERMG | DE000SL0A030 |
| Prime Treatments, Testing and Advancements Index NTR | N/A | .PGERMN | DE000SL0A022 |
| Prime Treatments, Testing and Advancements Index PR | N/A | .PGERMP | DE000SL0A014 |
INDEX COMPOSITION
| Component Name | Ticker | Weight |
|---|---|---|
| MODERNA INC | MRNA | 12.38% |
| BIONTECH SE | BNTX | 8.78% |
| CUREVAC BV | CVAC | 5.65% |
| QUEST DIAGNOSTICS INC | DGX | 5.03% |
| BIO-RAD LABORATORIES INC | BIO | 4.98% |
| LABORATORY CRP OF AMER HLDGS | LH | 4.91% |
| ZAI LAB LTD | ZLAB | 4.42% |
| NOVAVAX INC | NVAX | 4.20% |
| QUIDEL CORP | QDEL | 3.99% |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 3.69% |
| VIR BIOTECHNOLOGY INC | VIR | 3.36% |
| ALNYLAM PHARMACEUTICALS INC | ALNY | 3.27% |
| OPKO HEALTH INC | OPK | 2.70% |
| EMERGENT BIOSOLUTIONS INC | EBS | 2.52% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 2.11% |
| I-MAB | IMAB | 1.91% |
| INOVIO PHARMACEUTICALS INC | INO | 1.83% |
| DICERNA PHARMACEUTICALS INC | DRNA | 1.61% |
| TRANSLATE BIO INC | TBIO | 1.42% |
| VAXCYTE INC | PCVX | 1.33% |
| VBI VACCINES INC | VBIV | 1.27% |
| LUMINEX CORP | LMNX | 0.97% |
| NANTKWEST INC | NK | 0.87% |
| BIOCRYST PHARMACEUTICALS INC | BCRX | 0.79% |
| ORASURE TECHNOLOGIES INC | OSUR | 0.75% |
| VAXART INC | VXRT | 0.74% |
| ENANTA PHARMACEUTICALS INC | ENTA | 0.73% |
| MERIDIAN BIOSCIENCE INC | VIVO | 0.69% |
| ABBVIE INC | ABBV | 0.63% |
| ALEXION PHARMACEUTICALS INC | ALXN | 0.62% |
| PFIZER INC | PFE | 0.61% |
| BRISTOL-MYERS SQUIBB CO | BMY | 0.57% |
| ABBOTT LABORATORIES | ABT | 0.56% |
| JOHNSON & JOHNSON | JNJ | 0.55% |
| TAKEDA PHARM-ADR | TAK | 0.55% |
| ASTRAZENECA PLC-SPONS ADR | AZN | 0.54% |
| SANOFI-ADR | SNY | 0.53% |
| ELI LILLY & CO | LLY | 0.53% |
| MERCK & CO. INC. | MRK | 0.53% |
| GLAXOSMITHKLINE PLC-SPON ADR | GSK | 0.52% |
| GILEAD SCIENCES INC | GILD | 0.51% |
| DYNAVAX TECHNOLOGIES CORP | DVAX | 0.49% |
| REGENERON PHARMACEUTICALS | REGN | 0.49% |
| SIGA TECHNOLOGIES INC | SIGA | 0.48% |
| XBIOTECH INC | XBIT | 0.47% |
| CEL-SCI CORP | CVM | 0.40% |
| CUE BIOPHARMA INC | CUE | 0.35% |
| OXFORD IMMUNOTEC GLOBAL PLC | OXFD | 0.33% |
| ATHERSYS INC | ATHX | 0.30% |
| ARBUTUS BIOPHARMA CORP | ABUS | 0.28% |
| PARATEK PHARMACEUTICALS INC | PRTK | 0.27% |
| CO-DIAGNOSTICS INC | CODX | 0.27% |
| HOOKIPA PHARMA INC | HOOK | 0.25% |
| CORMEDIX INC | CRMD | 0.23% |
| IBIO INC | IBIO | 0.23% |
| IMV INC | IMV | 0.20% |
| CHIMERIX INC | CMRX | 0.19% |
| ASSEMBLY BIOSCIENCES INC | ASMB | 0.17% |
| CONTRAFECT CORP | CFRX | 0.14% |
| ENOCHIAN BIOSCIENCES INC | ENOB | 0.12% |
| PHASEBIO PHARMACEUTICALS INC | PHAS | 0.10% |
| ENZO BIOCHEM INC | ENZ | 0.09% |